NURS 5334 ADVANCED PHARMACOLOGY ANTIMICROBIAL
THERAPIES 100- PRACTICE EXAM QUESTIONS AND CORRECT
ANSWERS PLUS RATIONALE NEW UPDATE 2026-2027 UTA
49 QUESTIONS
TABLE OF CONTENTS
# TOPIC
1 Apply PK/PD principles to optimize antimicrobial dosing and route selection
2 Differentiate empiric vs
3 Recognize mechanisms of antimicrobial resistance and their clinical implications
4 Implement antimicrobial stewardship strategies to improve outcomes and reduce resistance
5 Adjust antimicrobial regimens in renal/hepatic impairment, pregnancy, and critical illness
6 NURS 5334 Advanced Pharmacology Antimicrobial Therapies 100
7 Practice Exam Questions and Correct Answers plus Rationale New Update 2026
8 2027 UTA
9 Foundations of Advanced Pharmacology - Antimicrobial Therapies
10 Applied Advanced Pharmacology - Antimicrobial Therapies
11 Advanced Advanced Pharmacology - Antimicrobial Therapies
12 Advanced Pharmacology - Antimicrobial Therapies Review
ABSTRACT
This study document brings together 49 carefully worded exam questions drawn from NURS 5334
Advanced Pharmacology Antimicrobial Therapies 100- Practice Exam Questions and Correct
Answers plus Rationale New Update 2026-2027 UTA, with the strongest emphasis placed on Apply
PK/PD principles to optimize antimicrobial dosing and route selection, Differentiate empiric vs and
Recognize mechanisms of antimicrobial resistance and their clinical implications. Every item
follows the wording style and level of reasoning you meet in the real paper, and each one is paired
with a clear rationale so the correct choice is never a guess. Work through the set at your own
pace, mark the questions that slow you down, then come back to them until the reasoning feels
automatic. Learners who revise this way walk into the exam room recognising the pattern behind
the questions instead of meeting them for the first time. Keep going - steady, honest practice is
what turns a difficult paper into a comfortable pass.
Page 1
,Q1 APPLY PK/PD PRINCIPLES TO OPTIMIZE ANTIMICROBIAL DOSING AND ROUTE
SELECTION
A patient with MRSA bacteremia is receiving vancomycin. The AUC24/MIC ratio is
420 (MIC 1 mcg/mL). Which parameter best predicts clinical efficacy and guides
dose adjustment?
A. Peak concentration/MIC ratio
B. Time above MIC (T>MIC)
C. AUC24/MIC ratio CORRECT
D. Trough concentration alone
RATIONALE: For vancomycin, the AUC24/MIC ratio is the pharmacodynamic target (target
400-600) and is now preferred over trough-only monitoring per ASHP/IDSA guidelines. Peak/MIC
and T>MIC are not validated for vancomycin; trough alone is less predictive and can lead to
suboptimal dosing. The AUC24/MIC of 420 is within target, so no adjustment is needed based on
this parameter.
Q2 APPLY PK/PD PRINCIPLES TO OPTIMIZE ANTIMICROBIAL DOSING AND ROUTE
SELECTION
Which statement best describes the mechanism of resistance conferred by the
mecA gene in Staphylococcus aureus?
A. Production of beta-lactamase enzymes that hydrolyze penicillin
B. Altered penicillin-binding protein (PBP2a) with low affinity for beta-lactams CORRECT
C. Efflux pump overexpression reducing intracellular drug concentration
D. Porin channel mutations decreasing drug permeability
RATIONALE: mecA encodes PBP2a, a penicillin-binding protein with reduced affinity for most
beta-lactams, conferring methicillin resistance (MRSA). Beta-lactamase production (A) is
mediated by blaZ and causes penicillin resistance but not methicillin resistance. Efflux pumps (C)
and porin mutations (D) are mechanisms seen in Gram-negative resistance, not the primary
mecA mechanism.
Page 2
, Q3 APPLY PK/PD PRINCIPLES TO OPTIMIZE ANTIMICROBIAL DOSING AND ROUTE
SELECTION
A patient with severe penicillin allergy (anaphylaxis) requires treatment for
community-acquired pneumonia. Which antibiotic is most appropriate?
A. Amoxicillin-clavulanate
B. Ceftriaxone
C. Levofloxacin CORRECT
D. Aztreonam
RATIONALE: Levofloxacin, a fluoroquinolone, is safe in severe penicillin allergy and covers
typical CAP pathogens. Amoxicillin-clavulanate (A) and ceftriaxone (B) are beta-lactams with
potential cross-reactivity. Aztreonam (D) is safe in penicillin allergy but lacks coverage for
Gram-positive pathogens like Streptococcus pneumoniae, making it inadequate for empiric CAP
monotherapy.
Q4 APPLY PK/PD PRINCIPLES TO OPTIMIZE ANTIMICROBIAL DOSING AND ROUTE
SELECTION
Which antimicrobial exhibits concentration-dependent killing and prolonged
post-antibiotic effect, allowing once-daily dosing?
A. Penicillin G
B. Gentamicin CORRECT
C. Vancomycin
D. Clindamycin
RATIONALE: Aminoglycosides like gentamicin exhibit concentration-dependent killing and a
prolonged post-antibiotic effect, supporting once-daily dosing for efficacy and reduced toxicity.
Penicillin G (A) and clindamycin (D) are time-dependent killers. Vancomycin (C) is
time-dependent with AUC/MIC as the PD target, not concentration-dependent.
Page 3
THERAPIES 100- PRACTICE EXAM QUESTIONS AND CORRECT
ANSWERS PLUS RATIONALE NEW UPDATE 2026-2027 UTA
49 QUESTIONS
TABLE OF CONTENTS
# TOPIC
1 Apply PK/PD principles to optimize antimicrobial dosing and route selection
2 Differentiate empiric vs
3 Recognize mechanisms of antimicrobial resistance and their clinical implications
4 Implement antimicrobial stewardship strategies to improve outcomes and reduce resistance
5 Adjust antimicrobial regimens in renal/hepatic impairment, pregnancy, and critical illness
6 NURS 5334 Advanced Pharmacology Antimicrobial Therapies 100
7 Practice Exam Questions and Correct Answers plus Rationale New Update 2026
8 2027 UTA
9 Foundations of Advanced Pharmacology - Antimicrobial Therapies
10 Applied Advanced Pharmacology - Antimicrobial Therapies
11 Advanced Advanced Pharmacology - Antimicrobial Therapies
12 Advanced Pharmacology - Antimicrobial Therapies Review
ABSTRACT
This study document brings together 49 carefully worded exam questions drawn from NURS 5334
Advanced Pharmacology Antimicrobial Therapies 100- Practice Exam Questions and Correct
Answers plus Rationale New Update 2026-2027 UTA, with the strongest emphasis placed on Apply
PK/PD principles to optimize antimicrobial dosing and route selection, Differentiate empiric vs and
Recognize mechanisms of antimicrobial resistance and their clinical implications. Every item
follows the wording style and level of reasoning you meet in the real paper, and each one is paired
with a clear rationale so the correct choice is never a guess. Work through the set at your own
pace, mark the questions that slow you down, then come back to them until the reasoning feels
automatic. Learners who revise this way walk into the exam room recognising the pattern behind
the questions instead of meeting them for the first time. Keep going - steady, honest practice is
what turns a difficult paper into a comfortable pass.
Page 1
,Q1 APPLY PK/PD PRINCIPLES TO OPTIMIZE ANTIMICROBIAL DOSING AND ROUTE
SELECTION
A patient with MRSA bacteremia is receiving vancomycin. The AUC24/MIC ratio is
420 (MIC 1 mcg/mL). Which parameter best predicts clinical efficacy and guides
dose adjustment?
A. Peak concentration/MIC ratio
B. Time above MIC (T>MIC)
C. AUC24/MIC ratio CORRECT
D. Trough concentration alone
RATIONALE: For vancomycin, the AUC24/MIC ratio is the pharmacodynamic target (target
400-600) and is now preferred over trough-only monitoring per ASHP/IDSA guidelines. Peak/MIC
and T>MIC are not validated for vancomycin; trough alone is less predictive and can lead to
suboptimal dosing. The AUC24/MIC of 420 is within target, so no adjustment is needed based on
this parameter.
Q2 APPLY PK/PD PRINCIPLES TO OPTIMIZE ANTIMICROBIAL DOSING AND ROUTE
SELECTION
Which statement best describes the mechanism of resistance conferred by the
mecA gene in Staphylococcus aureus?
A. Production of beta-lactamase enzymes that hydrolyze penicillin
B. Altered penicillin-binding protein (PBP2a) with low affinity for beta-lactams CORRECT
C. Efflux pump overexpression reducing intracellular drug concentration
D. Porin channel mutations decreasing drug permeability
RATIONALE: mecA encodes PBP2a, a penicillin-binding protein with reduced affinity for most
beta-lactams, conferring methicillin resistance (MRSA). Beta-lactamase production (A) is
mediated by blaZ and causes penicillin resistance but not methicillin resistance. Efflux pumps (C)
and porin mutations (D) are mechanisms seen in Gram-negative resistance, not the primary
mecA mechanism.
Page 2
, Q3 APPLY PK/PD PRINCIPLES TO OPTIMIZE ANTIMICROBIAL DOSING AND ROUTE
SELECTION
A patient with severe penicillin allergy (anaphylaxis) requires treatment for
community-acquired pneumonia. Which antibiotic is most appropriate?
A. Amoxicillin-clavulanate
B. Ceftriaxone
C. Levofloxacin CORRECT
D. Aztreonam
RATIONALE: Levofloxacin, a fluoroquinolone, is safe in severe penicillin allergy and covers
typical CAP pathogens. Amoxicillin-clavulanate (A) and ceftriaxone (B) are beta-lactams with
potential cross-reactivity. Aztreonam (D) is safe in penicillin allergy but lacks coverage for
Gram-positive pathogens like Streptococcus pneumoniae, making it inadequate for empiric CAP
monotherapy.
Q4 APPLY PK/PD PRINCIPLES TO OPTIMIZE ANTIMICROBIAL DOSING AND ROUTE
SELECTION
Which antimicrobial exhibits concentration-dependent killing and prolonged
post-antibiotic effect, allowing once-daily dosing?
A. Penicillin G
B. Gentamicin CORRECT
C. Vancomycin
D. Clindamycin
RATIONALE: Aminoglycosides like gentamicin exhibit concentration-dependent killing and a
prolonged post-antibiotic effect, supporting once-daily dosing for efficacy and reduced toxicity.
Penicillin G (A) and clindamycin (D) are time-dependent killers. Vancomycin (C) is
time-dependent with AUC/MIC as the PD target, not concentration-dependent.
Page 3
